Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All aspirin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAspirinAspirin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Aspirin use is associated with decreased inpatient mortality in patients with COVID-19: A meta-analysis

Srinivasan et al., American Heart Journal Plus: Cardiology Research and Practice, doi:10.1016/j.ahjo.2022.100191
Aug 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 29% Improvement Relative Risk Aspirin for COVID-19  Srinivasan et al.  META ANALYSIS c19early.org Favorsaspirin Favorscontrol 0 0.5 1 1.5 2+
Meta analysis of 14 studies with 164,539 patients, showing lower mortality with aspirin.
4 meta analyses show significant improvements with aspirin for mortality1-3, mechanical ventilation1, and progression4.
Currently there are 73 aspirin for COVID-19 studies, showing 11% lower mortality [5‑17%], 5% lower ventilation [-5‑15%], 4% lower ICU admission [-13‑18%], 1% higher hospitalization [-4‑6%], and 5% fewer cases [-5‑14%].
risk of death, 29.0% lower, RR 0.71, p < 0.001.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Srinivasan et al., 11 Aug 2022, peer-reviewed, 8 authors. Contact: kayani@bcm.edu.
This PaperAspirinAll
Aspirin use is associated with decreased inpatient mortality in patients with COVID-19: A meta-analysis
Aswin Srinivasan, Jonathan Brown, Pavitra Parimala Krishnamani, Brendon Cornett, MD Ramesh Babu Kesavan, Siva T Sarva, Syed Arman Raza, Waleed Tallat Kayani
American Heart Journal Plus: Cardiology Research and Practice, doi:10.1016/j.ahjo.2022.100191
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Declaration of interests ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: . J o u r n a l P r e -p r o o f
References
Ahmed, Merrell, Ismail, Rationales and uncertainties for aspirin use in COVID-19: a narrative review, Fam Med Community Health, doi:10.1136/fmch-2020-000741
Bianconi, Violi, Fallarino, Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19?, Drugs
Chow, Khanna, Kethirddy, Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019, Anesth Analg
Chow, Rahnavard, Gomberg-Maitland, o u r n a l P r e -p r o o f Journal Pre-proof
Chow, Yin, Yamane, Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis, J Thromb Haemost, doi:10.1111/jth.15517
Investigators, Association of Early Aspirin Use with In-Hospital Mortality in Patients with Moderate COVID-19, JAMA Netw Open, doi:10.1001/jamanetworkopen.2022.3890
J O U R N A L P R E, -p r o o f
Klok, Kruip, Van Der Meer, Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis, Thromb Res, doi:10.1016/j.thromres.2020.04.041
Mcfadyen, Stevens, Peter, The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications, Circ Res, doi:10.1161/CIRCRESAHA.120.317447
Mehta, Mcauley, Brown, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet
Santoro, Nuñez-Gil, Vitale, Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry, Heart, doi:10.1136/heartjnl-2021-319552
{ 'indexed': {'date-parts': [[2022, 8, 11]], 'date-time': '2022-08-11T04:41:29Z', 'timestamp': 1660192889115}, 'reference-count': 10, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 8, 1]], 'date-time': '2022-08-01T00:00:00Z', 'timestamp': 1659312000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2022, 8, 8]], 'date-time': '2022-08-08T00:00:00Z', 'timestamp': 1659916800000}, 'content-version': 'vor', 'delay-in-days': 7, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 8]]}, 'DOI': '10.1016/j.ahjo.2022.100191', 'type': 'journal-article', 'created': {'date-parts': [[2022, 8, 11]], 'date-time': '2022-08-11T04:08:17Z', 'timestamp': 1660190897000}, 'page': '100191', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Aspirin use is associated with decreased inpatient mortality in patients with COVID-19: A ' 'meta-analysis', 'prefix': '10.1016', 'author': [ {'given': 'Aswin', 'family': 'Srinivasan', 'sequence': 'first', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Pavitra Parimala', 'family': 'Krishnamani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brendon', 'family': 'Cornett', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramesh Babu', 'family': 'Kesavan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Siva T.', 'family': 'Sarva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Syed Arman', 'family': 'Raza', 'sequence': 'additional', 'affiliation': []}, {'given': 'Waleed Tallat', 'family': 'Kayani', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '4', 'key': '10.1016/j.ahjo.2022.100191_bb0005', 'doi-asserted-by': 'crossref', 'first-page': '571', 'DOI': '10.1161/CIRCRESAHA.120.317447', 'article-title': 'The emerging threat of (Micro)Thrombosis in COVID-19 and its ' 'therapeutic implications', 'volume': '127', 'author': 'McFadyen', 'year': '2020', 'journal-title': 'Circ. Res.'}, { 'key': '10.1016/j.ahjo.2022.100191_bb0010', 'doi-asserted-by': 'crossref', 'first-page': '148', 'DOI': '10.1016/j.thromres.2020.04.041', 'article-title': 'Confirmation of the high cumulative incidence of thrombotic ' 'complications in critically ill ICU patients with COVID-19: an updated ' 'analysis', 'volume': '191', 'author': 'Klok', 'year': '2020', 'journal-title': 'Thromb. Res.'}, { 'issue': '2', 'key': '10.1016/j.ahjo.2022.100191_bb0015', 'article-title': 'Rationales and uncertainties for aspirin use in COVID-19: a narrative ' 'review', 'volume': '9', 'author': 'Sayed Ahmed', 'year': '2021', 'journal-title': 'Fam. Med. Community Health'}, { 'issue': '10320', 'key': '10.1016/j.ahjo.2022.100191_bb0020', 'doi-asserted-by': 'crossref', 'first-page': '143', 'DOI': '10.1016/S0140-6736(21)01825-0', 'article-title': 'Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): ' 'randomized, controlled, open-label, platform trial', 'volume': '399', 'year': '2022', 'journal-title': 'Lancet'}, { 'issue': '3', 'key': '10.1016/j.ahjo.2022.100191_bb0025', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2022.3890', 'article-title': 'N3C consortium and ANCHOR investigators. Association of Early Aspirin ' 'use with in-hospital mortality in patients with moderate COVID-19', 'volume': '5', 'author': 'Chow', 'year': '2022', 'journal-title': 'JAMA Netw. Open'}, { 'issue': '11', 'key': '10.1016/j.ahjo.2022.100191_bb0030', 'doi-asserted-by': 'crossref', 'first-page': '2814', 'DOI': '10.1111/jth.15517', 'article-title': 'Association of prehospital antiplatelet therapy with survival in ' 'patients hospitalized with COVID-19: a propensity score-matched ' 'analysis', 'volume': '19', 'author': 'Chow', 'year': '2021', 'journal-title': 'J. Thromb. Haemost.'}, { 'key': '10.1016/j.ahjo.2022.100191_bb0035', 'doi-asserted-by': 'crossref', 'first-page': '930', 'DOI': '10.1213/ANE.0000000000005292', 'article-title': 'Aspirin use is associated with decreased mechanical ventilation, ' 'intensive care unit admission, and in-hospital mortality in ' 'hospitalized patients with coronavirus disease 2019', 'volume': '132', 'author': 'Chow', 'year': '2021', 'journal-title': 'Anesth. Analg.'}, { 'key': '10.1016/j.ahjo.2022.100191_bb0040', 'doi-asserted-by': 'crossref', 'first-page': '1383', 'DOI': '10.1007/s40265-020-01365-1', 'article-title': 'Is acetylsalicylic acid a safe and potentially useful choice for adult ' 'patients with COVID-19?', 'volume': '80', 'author': 'Bianconi', 'year': '2020', 'journal-title': 'Drugs'}, { 'key': '10.1016/j.ahjo.2022.100191_bb0045', 'doi-asserted-by': 'crossref', 'first-page': '1033', 'DOI': '10.1016/S0140-6736(20)30628-0', 'article-title': 'COVID-19: consider cytokine storm syndromes and immunosuppression', 'volume': '395', 'author': 'Mehta', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '2', 'key': '10.1016/j.ahjo.2022.100191_bb0050', 'doi-asserted-by': 'crossref', 'first-page': '130', 'DOI': '10.1136/heartjnl-2021-319552', 'article-title': 'Antiplatelet therapy and outcome in COVID-19: the health outcome ' 'predictive evaluation registry', 'volume': '108', 'author': 'Santoro', 'year': '2022', 'journal-title': 'Heart'}], 'container-title': 'American Heart Journal Plus: Cardiology Research and Practice', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2666602222001082?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2666602222001082?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 8, 11]], 'date-time': '2022-08-11T04:08:27Z', 'timestamp': 1660190907000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2666602222001082'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 8]]}, 'references-count': 10, 'alternative-id': ['S2666602222001082'], 'URL': 'http://dx.doi.org/10.1016/j.ahjo.2022.100191', 'relation': {}, 'ISSN': ['2666-6022'], 'subject': ['General Medicine'], 'container-title-short': 'American Heart Journal Plus: Cardiology Research and Practice', 'published': {'date-parts': [[2022, 8]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Aspirin use is associated with decreased inpatient mortality in patients with ' 'COVID-19: A meta-analysis', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'American Heart Journal Plus: Cardiology Research and Practice', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ahjo.2022.100191', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2022 Published by Elsevier Inc.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '100191'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit